SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $209,312 | -79.9% | 5,868 | -85.8% | 0.01% | -71.1% |
| Q4 2020 | $1,041,000 | +371.0% | 41,357 | +289.7% | 0.04% | +350.0% |
| Q3 2020 | $221,000 | -54.4% | 10,612 | -48.0% | 0.01% | -60.0% |
| Q2 2020 | $485,000 | -87.4% | 20,427 | -87.4% | 0.02% | -85.2% |
| Q4 2019 | $3,846,000 | +176.3% | 162,156 | +308.1% | 0.17% | +101.2% |
| Q1 2019 | $1,392,000 | -7.3% | 39,731 | -12.1% | 0.08% | -30.0% |
| Q4 2018 | $1,501,000 | -54.3% | 45,197 | -17.7% | 0.12% | -53.1% |
| Q2 2018 | $3,286,000 | +5.6% | 54,903 | -19.2% | 0.26% | +23.7% |
| Q1 2018 | $3,111,000 | +78.4% | 67,922 | +55.2% | 0.21% | +72.5% |
| Q4 2017 | $1,744,000 | -12.3% | 43,767 | -11.9% | 0.12% | -28.1% |
| Q3 2017 | $1,988,000 | -36.9% | 49,690 | -32.0% | 0.17% | -41.2% |
| Q2 2017 | $3,151,000 | +132.7% | 73,110 | +69.0% | 0.28% | +111.9% |
| Q1 2017 | $1,354,000 | +1.7% | 43,272 | -19.6% | 0.13% | -3.6% |
| Q3 2016 | $1,332,000 | +28.3% | 53,849 | +5.7% | 0.14% | +87.8% |
| Q2 2016 | $1,038,000 | +396.7% | 50,965 | +272.6% | 0.07% | +362.5% |
| Q1 2016 | $209,000 | -85.0% | 13,680 | -86.3% | 0.02% | -86.6% |
| Q3 2015 | $1,396,000 | +4.1% | 99,520 | +26.1% | 0.12% | -9.2% |
| Q2 2015 | $1,341,000 | +707.8% | 78,951 | +474.3% | 0.13% | +495.5% |
| Q1 2015 | $166,000 | – | 13,748 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |